Cell Therapy

Cell Therapy development and manufacturing

The expert NecstGen team provides process development and manufacturing solutions for your Cell Therapies.


Development

  • Translational activities to create GMP compliant manufacturing
  • Process design and optimisation
  • Scale-up to clinically relevant volumes
  • Automation and closed processes

Manufacturing

  • Pre-clinical or toxicology study material
  • Phase I, Phase II clinical trial material

Cell Therapies

Talk to NecstGen today about your needs for:

  • Induced Pluripotent Stem Cells (iPSC)
  • Chimeric Antigen Receptor T-Cells (CAR-T), Tumor Infiltrating Lymphocytes (TIL) T-Cell Receptor Modified T-Cells (TCR-T)
  • Natural Killer (NK) Cells/CAR-NK Cells
  • Dendritic Cells (DC)
  • Mesenchymal Stromal Cells (MSC)

Tristan Pritchard-Meaker
Business Development

Netherlands Center for the Clinical Advancement of Stem Cell & Gene Therapies

NECSTGEN LOGO

Netherlands Center for the
Clinical Advancement of
Stem Cell & Gene Therapies

NecstGen

Visiting adress
Sylviusweg 62
2333 BE Leiden
Leiden Bio Science Park
The Netherlands

Contact Us